Chen-Plotkin, Alice S.Albin, RogerAlcalay, RoyBabcock, DebraBajaj, VikramBowman, DuboisBuko, AlexCedarbaum, JesseChelsky, DanielCookson, MarkDawson, TedDewey, RichardForoud, TatianaFrasier, MarkGerman, DwightGwinn, KatrinaHuang, XuemeiKopil, CatherineKremer, ThomasLasch, ShirleyMarek, KenMarto, JarrodMerchant, KalpanaMollenhauer, BritNaito, AnnaPotashkin, JudithReimer, AlyssaRosenthal, LianaSaunders-Pullman, RachelScherzer, Clemens R.Sherer, ToddSingleton, AndrewSutherland, MargaretThiele, Inesvan der Brug, MarcelVan Keuren-Jensen, KendallVaillancourt, DavidWalt, DavidWest, AndrewZhang, Jing2019-10-112019-10-112018-08-15Chen-Plotkin, A. S., Albin, R., Alcalay, R., Babcock, D., Bajaj, V., Bowman, D., … Zhang, J. (2018). Finding useful biomarkers for Parkinson's disease. Science translational medicine, 10(454), eaam6003. doi:10.1126/scitranslmed.aam6003https://hdl.handle.net/1805/21126Parkinson’s Disease affects more than 4 million people worldwide, and biomarkers to bolster the therapeutic development pipeline are urgently needed. The recent advent of an “ecosystem” of shared biosample biorepositories and data enables us to consider how to focus PD biomarker activity to best translate efforts into real-world impact.en-USPublisher PolicyParkinson’s DiseaseBiomarkersBiosample biorepositoriesArticle